SELLAS regains Nasdaq minimum bid price compliance effective March 11, 2024

SELLAS Life Sciences Group, Inc.

Nasdaq confirmed compliance after closing bid price above $1.00 for 10 consecutive business days through March 8, 2024.
Company had been notified of non-compliance on February 14, 2024, and given a 180-day grace period until August 12, 2024.
Non-compliance matter is now closed; no further action required.
This removes a potential delisting risk for SELLAS common stock (SLS).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.